<code id='27F6A808C3'></code><style id='27F6A808C3'></style>
    • <acronym id='27F6A808C3'></acronym>
      <center id='27F6A808C3'><center id='27F6A808C3'><tfoot id='27F6A808C3'></tfoot></center><abbr id='27F6A808C3'><dir id='27F6A808C3'><tfoot id='27F6A808C3'></tfoot><noframes id='27F6A808C3'>

    • <optgroup id='27F6A808C3'><strike id='27F6A808C3'><sup id='27F6A808C3'></sup></strike><code id='27F6A808C3'></code></optgroup>
        1. <b id='27F6A808C3'><label id='27F6A808C3'><select id='27F6A808C3'><dt id='27F6A808C3'><span id='27F6A808C3'></span></dt></select></label></b><u id='27F6A808C3'></u>
          <i id='27F6A808C3'><strike id='27F6A808C3'><tt id='27F6A808C3'><pre id='27F6A808C3'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:comprehensive    Page View:392
          Rep. Larry Bucshon (R-Ind.) received a significant amount of campaign donations from the pharmaceutical industry in the second quarter of 2023. House Television via AP

          WASHINGTON — The pharmaceutical industry has been flooding the campaign coffers of Rep. Larry Bucshon, a cardiothoracic surgeon and Republican from Indiana, according to a STAT analysis of this quarter’s filings.

          CEOs of pharmaceutical giants, executives of the brand-drug lobby PhRMA, and companies’ political action committees all gave in higher-than-usual numbers to the rank-and-file House member last quarter. The total was nearly $56,000 between April 14 and June 30.

          advertisement

          Bucshon is a member of the House Energy & Commerce Committee, which works on drug pricing issues, and the GOP Doctors Caucus, but he doesn’t hold leadership positions in either.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more
          What the Wegovy shortage looks like for doctors — and for patients
          What the Wegovy shortage looks like for doctors — and for patients

          Afterphysicallydebilitatingcancertreatment,LaurieBrunnerencounteredanothermedicalhurdle:Shehaddevelo

          read more
          Heart attack and stroke risk calculators need revising
          Heart attack and stroke risk calculators need revising

          AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

          read more

          Akero's treatment for NASH falls short in cirrhosis study

          AdobeAkeroTherapeuticssaidTuesdaythatanexperimentalmedicinefailedtoshowasignificantbenefitforpatient